Skip to content

Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children

Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00822380
Enrollment
680
Registered
2009-01-14
Start date
2003-03-31
Completion date
2004-11-30
Last updated
2009-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

Anemia, Iron, Children, Micronutrients

Brief summary

Anemia continues to be a major public health problem in many regions of the world and it is still not clear which strategy is more effective in children population in terms of adherence and efficacy. The objective was to evaluate the efficacy and acceptance of several strategies that have been recently recommended to treat anemia on anemic children (6 to 43 mo):Iron supplement, iron+folic acid supplement, a multiple micronutrients supplement a micronutrient fortified complementary food in the form of porridge powder or zinc+iron+ascorbic acid fortified water.

Interventions

DIETARY_SUPPLEMENTIron

Daily 20mg of ferrous sulfate in liquid solution during 4 months

DIETARY_SUPPLEMENTMultiple micronutrients supplement

Daily supplement with 10mg of iron plus several micronutrients following a formula designed to treat anemia in indigenous population in Mexico. During 4 months.

DIETARY_SUPPLEMENTmicronutrient fortified porridge powder

Daily powdered complementary food designed for a national program in Mexico with 10mg of iron plus several micronutrients during 4 months

DIETARY_SUPPLEMENTIron and ascorbic acid fortified water

A drink water product fortified with 6.7 mg ofiron, zinc and ascorbic acid. This product was asked to be used for drinking and for cooking for the child during 4 months.

DIETARY_SUPPLEMENTIron plus folic acid supplement

Daily liquid solution following the daily iron (12.5mg)and folic acid recommendation of UNICEF to treat anemia during 4 months

Sponsors

Procter and Gamble
CollaboratorINDUSTRY
Universidad Autonoma de Queretaro
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Months to 42 Months
Healthy volunteers
Yes

Inclusion criteria

* Hemoglobin less than 11.7g/dL and above 7.0g/dL

Exclusion criteria

* Breastfeeding * Chronic gastroenteritis * Any other severe illness

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026